Kindstar Globalgene Technology, Inc. Stock
Equities
9960
KYG5262E1044
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.61 HKD | +1.26% | -0.62% | -4.17% |
Sales 2024 * | 1.32B 182M 1.42B | Sales 2025 * | 1.61B 223M 1.74B | Capitalization | 1.4B 193M 1.51B |
---|---|---|---|---|---|
Net income 2024 * | 110M 15.19M 119M | Net income 2025 * | 133M 18.37M 143M | EV / Sales 2024 * | 1.06 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.87 x |
P/E ratio 2024 * |
13.4
x | P/E ratio 2025 * |
11.3
x | Employees | 3,125 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 53.13% |
1 day | +1.26% | ||
1 week | -0.62% | ||
Current month | +3.21% | ||
1 month | +4.55% | ||
3 months | +11.81% | ||
6 months | -3.59% | ||
Current year | -4.17% |
Managers | Title | Age | Since |
---|---|---|---|
Shi Ang Huang
CEO | Chief Executive Officer | 66 | 11-02-21 |
Hai Jie Chai
DFI | Director of Finance/CFO | 46 | 20-12-03 |
Zan Bing Tu
COO | Chief Operating Officer | 52 | 20-12-03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Zuie Chin Huang
BRD | Director/Board Member | 58 | 12-01-29 |
Xin Ping Xia
BRD | Director/Board Member | 59 | 21-02-22 |
Shi Ang Huang
CEO | Chief Executive Officer | 66 | 11-02-21 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-22 | 1.61 | +1.26% | 122 500 |
24-05-21 | 1.59 | -4.22% | 573,000 |
24-05-20 | 1.66 | +1.84% | 192,000 |
24-05-17 | 1.63 | +0.62% | 1,007,000 |
24-05-16 | 1.62 | +1.25% | 417,500 |
Delayed Quote Hong Kong S.E., May 22, 2024 at 04:08 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.17% | 194M | |
-23.47% | 8.01B | |
+67.47% | 4.3B | |
+0.32% | 2.55B | |
-9.11% | 2.46B | |
-39.22% | 2.44B | |
-8.65% | 1.89B | |
-17.46% | 1.59B | |
-40.70% | 1.21B | |
+13.38% | 1.17B |
- Stock Market
- Equities
- 9960 Stock